The United States has taken a monumental step by withdrawing from the World Health Organization (WHO), marking a significant shift in its approach to global health diplomacy. This decision, backed by President Donald Trump, was finalized on January 22, 2026, following an Executive Order issued on January 20, 2025. Trump’s administration has pointed fingers at WHO for alleged failures in managing the COVID-19 pandemic and for its perceived closeness with China as key reasons for this drastic move.
In a pointed statement, President Trump laid bare his frustrations with WHO’s management. He noted, “We paid $500 million a year to the WHO. That’s a lot. What the HELL were they gonna do? And China paid $39 million for 1.4 billion people!” His financial comparisons underline a clear dissatisfaction with the organization’s funding methodologies. Trump went on to critique their pandemic response, saying, “On COVID, they were TOTALLY wrong.” This indicates a strong belief that the WHO’s strategies failed to align with America’s expectations or needs during the early phase of the pandemic.
The dissatisfaction reaches deeper than just financial contributions; it touches on serious issues of accountability and transparency. Trump accused the organization of being too beholden to China, claiming, “They refused to say that because they were totally owned by China.” This narrative frames the withdrawal not only as a rejection of WHO’s policies but also as a stance against what is seen as international influence compromising U.S. interests.
This exit from the WHO has far-reaching implications. Domestically, the U.S. ceases all funding, which includes about $111 million in assessed contributions and approximately $570 million in voluntary contributions annually. With this withdrawal, America steps back from WHO’s governance structures and technical engagements, which could hinder its ability to address global health challenges.
Globally, the absence of U.S. support puts the WHO in a precarious position. The organization could face a severe budget deficit, obstructing its efforts in critical areas like polio eradication, HIV response, and maternal health. In a statement reflecting this concern, WHO expressed regret over the U.S. exit, stating it “makes both the United States and the world less safe.” This illustrates the expected disruption in international health preparedness initiatives.
As the U.S. pivots, it appears intent on establishing new partnerships with non-governmental organizations (NGOs) and other nations to tackle global health issues. However, experts warn that without the established frameworks that WHO provides, these new endeavors may struggle to offer the same level of impact or coordination.
Analysts and health advocates have raised alarms about the long-term consequences of the withdrawal. WHO Director-General Tedros Adhanom Ghebreyesus described the exit as a “loss for the US and the world,” stressing the importance of multilateral cooperation in facing health crises effectively.
Additionally, critics from public health circles attribute a portion of the pandemic’s toll to failures within U.S. domestic policy rather than placing all blame on WHO. Public health expert Drew Altman pointed out that “internal failures in American COVID-19 policy and leadership” significantly affected the country’s global health response, suggesting that looking outward for accountability may overlook essential self-reflection needed within the U.S. government.
On a broader scale, this withdrawal highlights a growing divide between nationalist policies and multilateral efforts in health governance. The change could instigate a shift towards prioritizing national interests, potentially undermining collective strategies critical for managing shared health threats. This threatens to create a fragmented response landscape, making coordinated efforts more challenging.
In response to U.S. criticisms, WHO has defended its pandemic actions, arguing that its responses were grounded in transparency and adherence to scientific evidence. The organization stated, “We acted quickly, shared all information it had rapidly and transparently with the world, and advised Member States on the basis of the best available evidence.” This defense showcases WHO’s stance on accountability and its commitment to protecting global health.
As WHO lays out its future strategies, it seeks to maintain its focus on combating health disparities and fostering international collaboration. However, the prospect of continuing ambitious global health initiatives, like the WHO Pandemic Agreement and pathogen sharing frameworks, appears challenging without U.S. funding. This could significantly impede progress in vital health areas where collective action is essential.
The U.S. plans to pursue health initiatives through bilateral efforts, yet the future of its engagement with global health cooperation hangs in the balance. As international entities and health advocates navigate this new reality, ongoing discussions will be critical in shaping future partnerships and policies aimed at safeguarding health worldwide.
"*" indicates required fields
